Related Experiment Videos
Prevalence of hypercalcaemia in patients on maintenance lithium therapy monitored in primary care
1Department of Psychiatry, National University of Ireland Galway, Galway. john.lally@kcl.ac.uk
Insights
Long-term lithium therapy can lead to hypercalcemia (high calcium levels) and hyperparathyroidism. Regular serum calcium monitoring is crucial for patients on lithium treatment to detect these potential issues.
Area of Science:
- Endocrinology
- Psychopharmacology
- Clinical Medicine
Background:
- Lithium is a common mood stabilizer for bipolar disorder.
- Current guidelines lack recommendations for calcium monitoring in lithium-treated patients.
- Hypercalcemia and hyperparathyroidism are potential side effects of lithium therapy.
Purpose of the Study:
- To determine the prevalence of hypercalcemia and hyperparathyroidism in long-term lithium users.
- To assess calcium monitoring practices in this patient group.
- To evaluate the need for routine calcium level screening.
Main Methods:
- Retrospective analysis of clinical and laboratory data.
- Inclusion of 333 patients on long-term lithium therapy.
- Review of serum lithium and calcium levels over a 2-year period.
Main Results:
- Prevalence of lithium-associated hypercalcemia was 5.3% (15 patients).
- Average lithium treatment duration for hypercalcemic patients was 15 years.
- 14% of patients lacked calcium level monitoring; 1% had hyperparathyroidism.
Conclusions:
- Regular serum calcium monitoring is necessary for patients on maintenance lithium treatment.
- Early detection of calcium dysfunction can prevent complications.
- This study highlights a gap in current clinical guidelines.
Abstract:
The purpose of this study was to ascertain the prevalence of hypercalcaemia and hyperparathyroidism in individuals on long term lithium therapy who were monitored by their general practitioners and living within the West Galway mental health catchment area. We also wished to assess the extent of screening for calcium dysfunction in this patient cohort.Current guidelines do not specify the need for calcium monitoring in patients on lithium therapy. We conducted a retrospective analysis of clinical and laboratory data collected as part of regular monitoring for patients on long term lithium treatment. Three hundred and thirty three patients had serum lithium levels monitored over a 2 year period. Fifteen patients (5.3%) had lithium associated hypercalcaemia. The mean duration of lithium treatment for those with hypercalcaemia was 15 years and these patients had a mean serum calcium level of 2.7mmol/L. Eighty six (14%) patients did not have a calcium level monitored over the 2 year period. Three patients (1%) were found to have hyperparathyroidism. This survey supports the need for regular monitoring of serum calcium levels in patients on maintenance lithium treatment.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Skeleton and Calcium Homeostasis
Urinary Tract Calculi I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi V: Nursing Management